Veru (VERU) Earnings Date & Reports

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS)... Show more

Industry: #Household Or Personal Care

Get AI intraday signals

A.I. Advisor

published Earnings

VERU is expected to report earnings to rise 15.00% to -5 cents per share on August 07

Q2'25

Est.

$-0.06

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.01

The last earnings report on May 08 showed earnings per share of -5 cents, beating the estimate of -5 cents. With 406.26K shares outstanding, the current market capitalization sits at 76.43M.

View a ticker or compare two or three

Compare

VERU